MD5Z - Method for eliminating the dislocation of the intraocular lens - Google Patents

Method for eliminating the dislocation of the intraocular lens

Info

Publication number
MD5Z
MD5Z MDS20080014A MDS20080014A MD5Z MD 5 Z MD5 Z MD 5Z MD S20080014 A MDS20080014 A MD S20080014A MD S20080014 A MDS20080014 A MD S20080014A MD 5 Z MD5 Z MD 5Z
Authority
MD
Moldova
Prior art keywords
dislocation
eliminating
intraocular lens
solution
lens
Prior art date
Application number
MDS20080014A
Other languages
Romanian (ro)
Russian (ru)
Inventor
Ион ЖЕРУ
Original Assignee
Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова filed Critical Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова
Priority to MDS20080014A priority Critical patent/MD5Z/en
Publication of MD5Y publication Critical patent/MD5Y/en
Publication of MD5Z publication Critical patent/MD5Z/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

The invention refers to ophthalmology, particularly to a method for eliminating the dislocation of the intraocular lens.Summary of the invention consists in that it is concomitantly administered subconjunctivally 0,3 ml of 1% Mezaton solution, intravenously 2,0 ml of Furosemide and per os 0,25 mg of Diacarb, then within 30 min in obscure conditions at direct illumination of cornea with the ophtalmoscope it is pressed with the microspatula on the region of limb, namely on the meridian of dislocation of the lens ansa up to its reposition under the iris, afterwards it is administered subconjunctivally a drop of 1% Pilocarpine solution.
MDS20080014A 2008-07-17 2008-07-17 Method for eliminating the dislocation of the intraocular lens MD5Z (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MDS20080014A MD5Z (en) 2008-07-17 2008-07-17 Method for eliminating the dislocation of the intraocular lens

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDS20080014A MD5Z (en) 2008-07-17 2008-07-17 Method for eliminating the dislocation of the intraocular lens

Publications (2)

Publication Number Publication Date
MD5Y MD5Y (en) 2009-02-28
MD5Z true MD5Z (en) 2009-09-30

Family

ID=45094332

Family Applications (1)

Application Number Title Priority Date Filing Date
MDS20080014A MD5Z (en) 2008-07-17 2008-07-17 Method for eliminating the dislocation of the intraocular lens

Country Status (1)

Country Link
MD (1) MD5Z (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD975Z (en) * 2015-01-28 2016-07-31 Национальный Центр Общественного Здоровья Министерства Здравоохранения Республики Молдова Method for donor blood testing for hepatitis B virus markers
  • 2008
    • 2008-07-17 MD MDS20080014A patent/MD5Z/en not_active IP Right Cessation

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Krupin T., Kolker A., Rosenberg L. Complications in ophthalmic surgery. II ed., Cicago Mosby, 1999, p. 74-75 *
Волков В., Бржевский В., Ушаков Н. Офтальмохирургия с использованием полимеров. Санкт-Петерсбург, Гиппократ, 2003, с. 245-246 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD975Z (en) * 2015-01-28 2016-07-31 Национальный Центр Общественного Здоровья Министерства Здравоохранения Республики Молдова Method for donor blood testing for hepatitis B virus markers

Also Published As

Publication number Publication date
MD5Y (en) 2009-02-28

Similar Documents

Publication Publication Date Title
WO2007104541A3 (en) Compositions and methods using serine protease inhibiting peptides for treating ophthalmic disorders
WO2006071548A3 (en) Aminopyrazine analogs for treating glaucoma and other rho kinase-mediated diseases
MX2011007804A (en) Sustained released delivery of one or more agents.
WO2008011836A3 (en) Ophthalmic solutions
MY159463A (en) Method and composition for treating ocular hypertension and glaucoma
WO2009137085A3 (en) Sustained release delivery of active agents to treat glaucoma and ocular hypertension
WO2013030679A3 (en) Sustained release delivery of active agents to treat glaucoma and ocular hypertension
WO2011084366A3 (en) Compositions and drug delivery systems for intraocular delivery of sirna molecules, their use for treating conditions
WO2009146151A3 (en) Corneal onlay devices and methods
TW200603775A (en) Anti-excitotoxic sustained release intraocular implants and related methods
EA200501018A1 (en) OPHTHALMOLOGICAL PREPARATION FOR PREVENTION AND TREATMENT OF PATIENTS WITH DISEASES
TW200833341A (en) 6-aminoimidazo[1,2-b]pyridazine analogs as rho kinase inhibitors for the treatment of rho kinase-mediated diseases and conditions
BR0302584A (en) Brimonidine and timolol combination for topical ophthalmic use
TW200744574A (en) Use of L-carnitine or of alkanoyl L-carnitines for the preparation of a physiological supplement of medicament for ophthalmic use in the form of eye-drops
TW200518760A (en) Triamcinolone acetonide and anecortave acetate formulations for injection
AR079683A1 (en) OPTICAL TOPIC FORMULATION OF PEPTIDES
NZ602479A (en) Pharmaceutical composition for the treatment of dry eye and/or corneal and conjunctival lesion
ATE508711T1 (en) PRE-FORMED INTRASTROMAL CORNEA INSERT FOR CORNEA ANOMALIES OR DYSTROPHIES
AU2010310788A1 (en) Compositions and methods for controlling pupil dilation comprising phentolamine
AR079696A1 (en) PHARMACEUTICAL COMPOSITIONS THAT INCLUDE BIMATOPROST, BRIMONIDINE AND TIMOLOL AND ITS USE TO PREPARE A USEFUL MEDICINAL PRODUCT TO REDUCE INTRAOCULAR PRESSURE
MD5Z (en) Method for eliminating the dislocation of the intraocular lens
EA201290958A1 (en) A METHOD FOR REDUCING INTRAGLASE PRESSURE IN PEOPLE USING N6-CYCLOPENTILADAINOSINE (CPA), CPA DERIVATIVES OR THEIR CLEARANCE
Gandorfer Diffuse diabetic macular edema: pathology and implications for surgery
CL2020001426A1 (en) Topical ophthalmic composition comprising dobesilic acid to treat diseases of the posterior segment of the eye.
AU2017261303A1 (en) Ophthalmic compositions

Legal Events

Date Code Title Description
FG9Y Short term patent issued
MK4Y Short term patent expired